{
    "2021-04-16": [
        [
            {
                "time": "2021-07-15",
                "original_text": "WHO says global COVID-19 cases nearly doubled in last two months, making vaccine drive more urgent than ever",
                "features": {
                    "keywords": [
                        "global",
                        "COVID-19",
                        "cases",
                        "doubled",
                        "vaccine",
                        "urgent"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-07-15",
                "original_text": "Glaxo (GSK)/ Vir Biotech COVID-19 Antibody Under Review in EU",
                "features": {
                    "keywords": [
                        "Glaxo",
                        "Vir Biotech",
                        "COVID-19",
                        "Antibody",
                        "Review",
                        "EU"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-07-15",
                "original_text": "UPDATE 2-Lilly asks FDA to not allow lone use of COVID-19 drug bamlanivimab",
                "features": {
                    "keywords": [
                        "Lilly",
                        "FDA",
                        "COVID-19",
                        "drug",
                        "bamlanivimab"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-07-15",
                "original_text": "Pharma Stock Roundup: JNJ's COVID-19 Vaccine Woes, MRK Ends COVID-19 Drug Development",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "JNJ",
                        "Vaccine",
                        "Woes",
                        "MRK",
                        "Drug",
                        "Development"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-07-15",
                "original_text": "Eli Lilly asks FDA to revoke EUA for COVID antibody treatment alone to speed transition to combination therapy",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "FDA",
                        "revoke",
                        "EUA",
                        "COVID",
                        "antibody",
                        "treatment",
                        "combination",
                        "therapy"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-07-15",
                "original_text": "Lilly requests revocation of emergency use authorization for bamlanivimab alone to complete transition to bamlanivimab and etesevimab together for treatment of COVID-19 in the U.S.",
                "features": {
                    "keywords": [
                        "Lilly",
                        "revocation",
                        "emergency",
                        "use",
                        "authorization",
                        "bamlanivimab",
                        "etesevimab",
                        "treatment",
                        "COVID-19",
                        "U.S."
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-07-15",
                "original_text": "Premarket Movers Friday - DraftKings, Morgan Stanley, Splunk",
                "features": {
                    "keywords": [
                        "Premarket",
                        "Movers",
                        "DraftKings",
                        "Morgan Stanley",
                        "Splunk"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology",
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}